OR5BT1P

Across TCGA pan-cancer cohorts, OR5BT1P RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated OR5BT1P data layer.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR5BT1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5BT1P expression acts as an unfavorable survival marker, although some lineages such as BLCA and ESCA show a favorable association.

COAD, BLCA, and LIHC are the cancer types where OR5BT1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Tertile	All	0.640	0.845	<.001	105	view →
BLCA	OS	Tertile	All	0.785	0.674	.005	49	view →
LIHC	OS	Tertile	All	0.575	0.803	.001	39	view →
KIRC	OS	Tertile	All	0.770	0.855	.006	21	view →
ESCA	OS	Tertile	All	0.810	0.598	.006	19	view →
PAAD	DFS	Median	All	0.469	0.292	.010	16	view →
OV	OS	Median	IV	0.255	0.495	.001	14	view →
ACC	OS	Median	III,IV	0.732	0.251	.007	12	view →
CHOL	DFS	Quartile	All	0.144	0.558	.003	11	view →
READ	DFS	Tertile	IV	0.179	0.671	<.001	9	view →
KICH	DFS	Median	II,III,IV	1.000	0.399	.002	7	view →
THCA	DFS	Quartile	III,IV	0.531	0.831	.037	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

OR5BT1P–COAD (OS)

Open the COAD breakdown →